Ampath Chats

Screening for Inhalant Allergy in South Africa

Ampath Chats
Screening for Inhalant Allergy in South Africa
Read Document

PATHCHAT Edition No. 31
Please contact your local Ampath pathologist for more information.

Author: Dr. Cathy van Rooyen, MBChB, MMed Path, FRC (Pathology)
Allergy, Immunology, and Virology Pathologist

Introduction

🔹 Allergic rhinitis and inhalant allergies are common conditions seen in primary care.

  • Misdiagnosis and suboptimal management can lead to:
    • Poor quality of life.
    • Uncontrolled asthma and frequent exacerbations.
    • Increased healthcare costs.
  • A rational and cost-effective approach to inhalant allergy screening is essential.

A structured diagnostic approach improves patient outcomes by:

  • Identifying sensitizing allergens.
  • Guiding allergen avoidance strategies.
  • Selecting patients for allergen immunotherapy.

Recognizing a History Suggestive of Inhalant Allergy

🔹 Key Symptoms Indicating Inhalant Allergy:

  • Frequent sneezing, nasal congestion, and postnasal drip.
  • Seasonal or perennial symptoms (e.g., worse in spring or with dust exposure).
  • Asthma exacerbations linked to specific triggers.
  • Eye irritation (itching, watering, redness).
  • Recurrent sinus infections due to chronic allergic inflammation.

Screening for inhalant allergy is recommended for symptomatic patients using:

  1. Phadiatop® inhalant screen (detects atopy but not specific allergens).
  2. Panel of inhalant skin prick tests or specific IgE blood tests.

📌 Phadiatop® is an atopy screening test, not an allergen mix. It detects broad allergenic responses and cross-reactivity but does not specify individual allergens.

Stepwise Approach to Inhalant Allergy Diagnosis

🔹 Step 1: Perform a Phadiatop® Inhalant Screen
A positive Phadiatop® test confirms atopy but does not identify specific allergens.
If positive, further testing is required to determine the offending allergen.

🔹 Step 2: Follow-Up Testing for Specific Inhalant Allergens
According to South African guidelines, the following inhalant allergens should be tested:

  • Bermuda grass pollen.
  • Rye grass pollen.
  • House dust mites (Dermatophygoides pteronyssinus and Blomia tropicalis).
  • Moulds (Alternaria alternata, Cladosporium herbarum, Aspergillus fumigatus).
  • Pet allergens (cat and dog dander).

🔹 Step 3: Consider Seasonal and Regional Factors
For patients with seasonal exacerbations (e.g., springtime allergies), additional testing for tree pollen IgE should be done:

  • Use a tree mix screen or test for specific tree pollen allergens in the patient’s environment.

Adjust testing based on the patient’s geographic location:

  • Western Cape & Eastern Cape: Add Epicoccum mould spores and German cockroach IgE.
  • KwaZulu-Natal: Add Oriental cockroach IgE.
  • Central & Northern South Africa: Add maize pollen, weed pollen mix (cosmos and khakibush), and Eucalyptus tree pollen IgE.

📌 Testing should be tailored to the patient's history and environmental exposure.

South African Inhalant Allergy Panel (SAARWG Panel)

🔹 The SAARWG (South African Rhinitis Working Group) recommends testing the following nine allergens:

Grass Pollens:

  • Bermuda grass.
  • Rye grass.

Moulds:

  • Alternaria alternata.
  • Cladosporium herbarum.
  • Aspergillus fumigatus.

House Dust Mites:

  • Blomia tropicalis.
  • Dermatophygoides pteronyssinus.

Pet Allergens:

  • Cat dander.
  • Dog dander.

Ampath’s Role in Inhalant Allergy Testing

Ampath supports the South African inhalant allergy testing guidelines.
Offers comprehensive testing, including Phadiatop® and specific IgE panels.
Consulting pathologists are available to assist with result interpretation and patient management.

Key Takeaways for Clinicians

A positive Phadiatop® test confirms atopy but does not specify the allergen—follow-up testing is necessary.
Testing should be guided by symptom history, seasonal triggers, and regional allergen exposure.
The SAARWG panel recommends testing for grass pollens, moulds, house dust mites, and pet allergens.
Ampath provides expert consulting services for interpreting inhalant allergy test results.